Jericho Financial’s Quest Diagnostics DGX Stock Holding History

Jericho Financial’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$378K	Buy	1,623 +1	+0.1%	+$231	0.19%	35
2026 Q2	$344K	Sell	1,622 -860	-35%	-$169K	0.18%	37
2026 Q1	$486K	Sell	2,482 -140	-5%	-$27.2K	0.31%	34
2025 Q4	$455K	Sell	2,622 -753	-22%	-$137K	0.27%	35
2025 Q3	$643K	Sell	3,375 -195	-5%	-$34.6K	0.39%	33
2025 Q2	$641K	Sell	3,570 -104	-3%	-$18.1K	0.42%	33
2025 Q1	$622K	Sell	3,674 -236	-6%	-$38.8K	0.45%	32
2024 Q4	$590K	Buy	+3,910	New	+$608K	0.43%	32

Other funds holding DGX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Jericho Financial's DGX Position: Q3 2026 in Review

Jericho Financial increased its Quest Diagnostics (DGX) stake by 0.06% in Q3 2026, buying an estimated $231 and bringing the position to 1,623 shares worth $378K. The position accounts for 0.19% of the portfolio, ranked #35.

Jericho Financial first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. The position peaked at $643K in Q3 2025. 605 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Jericho Financial held 1,623 shares of Quest Diagnostics worth $378K as of Q3 2026.
Jericho Financial bought 1 Quest Diagnostics share in Q3 2026, an estimated $231.
Quest Diagnostics made up 0.19% of Jericho Financial's portfolio in Q3 2026, its #35 holding.
Jericho Financial first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
Jericho Financial's Quest Diagnostics position peaked at $643K in Q3 2025.
605 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Jericho Financial's 13F filing for Q3 2026, filed 13 Oct 2026.